New opportunity to discuss the Impact of the New European Pharmacovigilance Legislation

Share Article

Impact of the New European Pharmacovigilance Legislation one-day meeting hosted by MAPI Research Trust.

MAPI Research Trust

meet with colleagues in other drug companies to learn how they are adapting to the new EU PV legislation and learn from their experiences

Held approximately 100 days after the 2 July effective date, Impact of the New European Pharmacovigilance Legislation is designed to promote discussion regarding current and ongoing implementation efforts. An array of industry and regulatory experts will be on hand 15 October at the BMA House in London to discuss ongoing efforts, successes and challenges. If you are in the planning phase or well into the implementation of this new legislation, please join us for this robust discussion.

Featured participants include experts from regulatory and industry:

  •     Xavier Kurz, PhV and RM, European Medicines Agency
  •     John Parkinson, Head of CPRD
  •     Claire Tilstone, Editor, The Medicines and Health Products Regulatory Agency
  •     Paul Dolin, Director, Takeda Pharmaceuticals
  •     Sinem Ezgi Gulmez, Associate Professor of Pharmacology, Pharmacoepidemiology and Drug Safety, University Bordeaux Segalen
  •     Francois Simondon, Epidemiology Executive Director, Sanofi Pasteur MSD
  •     Macey Murray, Teaching and Research Fellow, University College London, Centre for Paediatric Pharmacy Research
  •     Saad A.W. Shakir, MD, Director, Drug Safety Research Unit
  •     And more

Benefits of attendance include: Learn from experts in regulatory agencies about goals of new EU PV legislation and progress with implementation; Information sharing of company approaches and concerns pertaining to EU pharmacovigilance guidance – especially as related to post-authorisation studies and risk management plans; and Networking opportunities with participants.

Seating is limited and you are encouraged to register online to reserve your space. Early registration fees are available until September 20.

About MAPI Research Trust
MAPI Research Trust is a non-profit organization facilitating access to information in the fields of Patient-Reported Outcomes (PRO) and Epidemiology, promoting the use of scientific approaches in these fields and encouraging exchanges between academics, companies, and international organizations around the world. Founded in 1995, headquarters are located in Lyon, France.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Amy Wynn

Emily Murray
Follow us on
Visit website